Filing Details
- Accession Number:
- 0001209191-15-075019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-09 16:03:48
- Reporting Period:
- 2015-10-07
- Filing Date:
- 2015-10-09
- Accepted Time:
- 2015-10-09 16:03:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397906 | Albert Cha | C/O Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-07 | 13,352 | $11.00 | 303,206 | No | 4 | P | Indirect | By funds |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By funds |
Footnotes
- The reporting person is one of the managing members of Vivo Ventures VII, LLC ("VV LLC"), which is the general partner of each of Vivo Ventures Fund VII, L.P. ("VVF") and Vivo Ventures VII Affiliates Fund, L.P. ("VVAF"), the record holders of the securities, and may be deemed to share voting and dispositive power over the securities held by VVF and VVAF. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.